Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam T Hwang

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Investigative Dermatology|May 15, 2008
56th annual Montagna Symposium on the Biology of Skin: Epidermal T-cell interactions--clinicopathological and basic mechanismsKevin D Cooper, Richard D Sontheimer, Jan Dutz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytesAmelia Grover, Grace J Kim, Gregory Lizée, et al.
The Journal of Investigative Dermatology|August 17, 2012
CCR6 is required for epidermal trafficking of γδ-T cells in an IL-23-induced model of psoriasiform dermatitisTomotaka Mabuchi, Tej Pratap Singh, Tomonori Takekoshi, et al.
The Journal of Investigative Dermatology|January 17, 2020
A Small Molecule CCR2 Antagonist Depletes Tumor Macrophages and Synergizes with Anti-PD-1 in a Murine Model of Cutaneous T-Cell Lymphoma (CTCL)Xuesong Wu, Rajinder Singh, Daniel K Hsu, et al.
Cancer Immunology, Immunotherapy : CII|December 2, 2006
Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary locationTakashi Kakinuma, Hari Nadiminti, Anke S Lonsdorf, et al.
Blood|August 9, 2003
Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesisLei Yao, Ombretta Salvucci, Adela R Cardones, et al.
Pediatric Dermatology|August 27, 2009
Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutationDavid F McDermott, Bryan Gammon, Peter J Snijders, et al.
The Journal of Experimental Medicine|October 29, 2003
Immune evasion by murine melanoma mediated through CC chemokine receptor-10Takashi Murakami, Adela R Cardones, Steven E Finkelstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Cutting edge: rapid accumulation of epidermal CCL27 in skin-draining lymph nodes following topical application of a contact sensitizer recruits CCR10-expressing T cellsVictor Huang, Anke S Lonsdorf, Lei Fang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 16, 2009
Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma modelAndy J Chien, Erin C Moore, Anke S Lonsdorf, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Investigative Dermatology|May 15, 2008
56th annual Montagna Symposium on the Biology of Skin: Epidermal T-cell interactions--clinicopathological and basic mechanismsKevin D Cooper, Richard D Sontheimer, Jan Dutz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytesAmelia Grover, Grace J Kim, Gregory Lizée, et al.
The Journal of Investigative Dermatology|August 17, 2012
CCR6 is required for epidermal trafficking of γδ-T cells in an IL-23-induced model of psoriasiform dermatitisTomotaka Mabuchi, Tej Pratap Singh, Tomonori Takekoshi, et al.
The Journal of Investigative Dermatology|January 17, 2020
A Small Molecule CCR2 Antagonist Depletes Tumor Macrophages and Synergizes with Anti-PD-1 in a Murine Model of Cutaneous T-Cell Lymphoma (CTCL)Xuesong Wu, Rajinder Singh, Daniel K Hsu, et al.
Cancer Immunology, Immunotherapy : CII|December 2, 2006
Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary locationTakashi Kakinuma, Hari Nadiminti, Anke S Lonsdorf, et al.
Blood|August 9, 2003
Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesisLei Yao, Ombretta Salvucci, Adela R Cardones, et al.
Pediatric Dermatology|August 27, 2009
Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutationDavid F McDermott, Bryan Gammon, Peter J Snijders, et al.
The Journal of Experimental Medicine|October 29, 2003
Immune evasion by murine melanoma mediated through CC chemokine receptor-10Takashi Murakami, Adela R Cardones, Steven E Finkelstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Cutting edge: rapid accumulation of epidermal CCL27 in skin-draining lymph nodes following topical application of a contact sensitizer recruits CCR10-expressing T cellsVictor Huang, Anke S Lonsdorf, Lei Fang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 16, 2009
Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma modelAndy J Chien, Erin C Moore, Anke S Lonsdorf, et al.
Pageof 7